Collectively, the evidence supports the induction of IgM production in the acute phase of natural infection (peak prevalence: 20 days) followed by IgA (peak prevalence: 23 days), IgG (peak prevalence: 25 days), and nAbs (peak prevalence: 31 days) after symptom onset (111). Here, CD40LG is linked to infection.